Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Sjælland Forside
Hjælp og OSS
Link åbnes i en ny fane
Dansk
English
Søg efter indhold i Region Sjælland
Forside
Profiler
Forskningsenheder
Projekter
Publikationer
Priser
Aktiviteter
Undervisning og vejledning
Presse/medier
Impacts
Safety issues with bisphosphonate therapy for osteoporosis
Ernest Suresh
*
, Michael Pazianas
,
Bo Abrahamsen
*
Corresponding author af dette arbejde
Publikation
:
Bidrag til tidsskrift
›
Review
›
Forskning
›
peer review
Oversigt
Fingeraftryk
Fingeraftryk
Udforsk hvilke forskningsemner 'Safety issues with bisphosphonate therapy for osteoporosis' indeholder.
Sorter
Vægt
Alfabetisk
Keyphrases
Bisphosphonates
100%
Osteoporosis
100%
Bisphosphonate Therapy
100%
Safety Issues
100%
Fracture Risk
28%
During Pregnancy
14%
Clinical Trials
14%
High Dose
14%
Randomized Controlled Trial
14%
Absolute Risk
14%
Low Risk
14%
Oncology
14%
Drug Holiday
14%
Atypical Femur Fracture
14%
Clinical Data
14%
Atrial Fibrillation
14%
Esophageal Cancer
14%
Clinical Experience
14%
Epidemiological Data
14%
Long-term Users
14%
Lactation
14%
Osteonecrosis of the Jaw
14%
Severe Renal Impairment
14%
Safety Data
14%
Post-marketing Surveillance
14%
Evidence-based Management
14%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Clinical Trial
12%
Randomized Controlled Trial
12%
Malignant Neoplasm
12%
Femur Fracture
12%
Drug Holiday
12%
Atrial Fibrillation
12%
Jaw Osteonecrosis
12%
Severe Renal Impairment
12%
Postmarketing Surveillance
12%